This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In this article we discuss the challenges for manufacturers of therapeutics and diagnostics as they pursue the potential of companion diagnostics. Click below to read the article.
CRA surveyed 36 MedTech leaders to understand their strategic priorities and the impact of COVID-19 on their business. Survey respondents work in leadership...
Following a recent study on non-oncology orphan drug pricing in France, CRA’s Cécile Matthews was interviewed by reporter Francesca Bruce. The interview was...
Tim Wilsdon and Ryan Lawlor are panelist during the session titled “Vaccines funding in Europe: Ensuring sustainability in a post-pandemic world.” For more...
The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Similar to how...
